Feb 3 (Reuters) - French drugmaker Sanofi-Aventis (SASY.PA) could announce a deal to buy U.S. biotech Genzyme (GENZ.O) early next week if final negotiations between the companies go smoothly, Le Figaro reported on Thursday.
via reuters.com
Feb 3 (Reuters) - French drugmaker Sanofi-Aventis (SASY.PA) could announce a deal to buy U.S. biotech Genzyme (GENZ.O) early next week if final negotiations between the companies go smoothly, Le Figaro reported on Thursday.
